Contact
searchSearch
HMP Global
Login

ADHD Education Center

Featured

a girl playing a game on a tablet while lying on her stomach
Quiz
Test Your Knowledge—Digital Therapeutics: A Different Treatment Modality for ADHD
04/23/2026
How familiar are you with DTx for the treatment of attention-deficit/hyperactivity disorder? Test your knowledge with this short, multiple-choice quiz.
How familiar are you with DTx for the treatment of attention-deficit/hyperactivity disorder? Test your knowledge with this short, multiple-choice quiz.
How familiar are you with DTx...
04/23/2026
Psych Congress Network
A boy's hand holding a pill that says ADHD
Quiz
Long-Term Effects of Viloxazine ER in Treatment of Pediatric ADHD
04/23/2026
Ready to apply the data? Test your knowledge of viloxazine ER for the long-term treatment of pediatric ADHD.
Ready to apply the data? Test your knowledge of viloxazine ER for the long-term treatment of pediatric ADHD.
Ready to apply the data? Test...
04/23/2026
Psych Congress Network
a girl playing a game on a tablet while lying on her stomach
Commentary
Digital Therapeutics: A Different Treatment Modality for ADHD
04/23/2026
This article reviews the role of digital therapeutics (DTx) as an adjunctive treatment modality for ADHD, highlighting FDA‑cleared products alongside investigational interventions. It summarizes clinical evidence, safety, and use...
This article reviews the role of digital therapeutics (DTx) as an adjunctive treatment modality for ADHD, highlighting FDA‑cleared products alongside investigational interventions. It summarizes clinical evidence, safety, and use...
This article reviews the role of...
04/23/2026
Psych Congress Network
A boy's hand holding a pill that says ADHD
News
Open-Label Extension Trial Supports Long-Term Use of Viloxazine ER in Children and Adolescents
04/13/2026
A phase 3 open-label extension trial found viloxazine ER to be safe and effective for the long-term treatment of pediatric ADHD.
A phase 3 open-label extension trial found viloxazine ER to be safe and effective for the long-term treatment of pediatric ADHD.
A phase 3 open-label extension...
04/13/2026
Psych Congress Network
A teddy bear against a blue background wearing a mask and stethoscope.
News

ADHD Incidence Trends Accelerated After DSM-5 Changes and COVID-19 Disruptions
04/10/2026
Brionna Mendoza
Attention-deficit/hyperactivity disorder (ADHD) diagnosis rates in people younger than 30 years in British Columbia, Canada, rose steadily from 2003 to 2023 and appeared to accelerate after both DSM-5 implementation and the COVID-19 pandemic.
Attention-deficit/hyperactivity disorder (ADHD) diagnosis rates in people younger than 30 years in British Columbia, Canada, rose steadily from 2003 to 2023 and appeared to accelerate after both DSM-5 implementation and the COVID-19 pandemic.
Attention-deficit/hyperactivity...
04/10/2026
Psych Congress Network
Timothy Wilens, MD
Videos
Clinical Patterns of ADHD Comorbidities Across the Lifespan
04/01/2026
Timothy Wilens, MD
Timothy Wilens, MD, explores common patterns of attention-deficit/hyperactivity disorder (ADHD) psychiatric comorbidities throughout different developmental stages.
Timothy Wilens, MD, explores common patterns of attention-deficit/hyperactivity disorder (ADHD) psychiatric comorbidities throughout different developmental stages.
Timothy Wilens, MD, explores...
04/01/2026
Psych Congress Network
blocks spelling out the word "quiz"
Quiz
Screen Time, Brain Structure, and ADHD in Children
02/12/2026
Maria Mantas
Do you remember what the research says? Test your knowledge with this quick quiz!
Do you remember what the research says? Test your knowledge with this quick quiz!
Do you remember what the...
02/12/2026
Psych Congress Network
News
Co-occurring ADHD Associated With Poorer Health Outcomes in Adults With Autism on Medicaid
02/02/2026
Grace Taylor, MS, MA
A large US Medicaid study finds that co-occurring attention-deficit/hyperactivity disorder (ADHD) is common among adults with autism and is linked to higher rates of substance use, cardiovascular conditions, and injury, while ADHD medication...
A large US Medicaid study finds that co-occurring attention-deficit/hyperactivity disorder (ADHD) is common among adults with autism and is linked to higher rates of substance use, cardiovascular conditions, and injury, while ADHD medication...
A large US Medicaid study finds...
02/02/2026
First Report Managed Care
From First Report Managed Care
illustration of a laptop screen displaying a test
Quiz
Stimulants and Psychosis Risk in ADHD
12/22/2025
Maria Mantas
Do you remember the findings from this systematic review?
Do you remember the findings from this systematic review?
Do you remember the findings...
12/22/2025
Psych Congress Network
A young boy sits at a desk in a classroom
News
Higher Screen Time Tied to ADHD Symptoms, Altered Brain Structure in Children
12/03/2025
Brionna Mendoza
Higher digital screen time in preadolescent children is associated with worsening attention-deficit/hyperactivity disorder (ADHD) symptoms and measurable alterations in brain structure.
Higher digital screen time in preadolescent children is associated with worsening attention-deficit/hyperactivity disorder (ADHD) symptoms and measurable alterations in brain structure.
Higher digital screen time in...
12/03/2025
Psych Congress Network
A woman sleeping peacefully
Quiz
Test Your Knowledge – ADHD and Sleep: Why Non-Stimulants Might Be the Right Choice (Part 3)
10/09/2025
Sleep and ADHD intersect—see if your management playbook is up to date in 3 quick questions.
Sleep and ADHD intersect—see if your management playbook is up to date in 3 quick questions.
Sleep and ADHD intersect—see if...
10/09/2025
Psych Congress Network

Videos

Timothy Wilens, MD
Videos
Clinical Patterns of ADHD Comorbidities Across the Lifespan
04/01/2026
Timothy Wilens, MD
Timothy Wilens, MD, explores common patterns of attention-deficit/hyperactivity disorder (ADHD) psychiatric comorbidities throughout different developmental stages.
Timothy Wilens, MD, explores common patterns of attention-deficit/hyperactivity disorder (ADHD) psychiatric comorbidities throughout different developmental stages.
Timothy Wilens, MD, explores...
04/01/2026
Psych Congress Network
Greg Mattingly, MD
Videos
Breaking Down Treatment Barriers for Girls and Women With ADHD
07/24/2025
Greg Mattingly, MD
In this video, Psych Congress Co-Chair Greg Mattingly, MD, dives into the factors that prevent girls and women from receiving ADHD diagnoses earlier in life.
In this video, Psych Congress Co-Chair Greg Mattingly, MD, dives into the factors that prevent girls and women from receiving ADHD diagnoses earlier in life.
In this video, Psych Congress...
07/24/2025
Psych Congress Network
Sarah Slabaugh
Videos
Assessing Shame-Based Family Dynamics When Treating Children With ADHD
06/19/2025
Sarah Slabaugh, DO
Filmed ahead of her 2025 Psych Congress Elevate session, Sarah Slabaugh, DO, offers practical insights on identifying dysfunctional family patterns that may impact the presentation of ADHD symptoms in child and adolescent patients.
Filmed ahead of her 2025 Psych Congress Elevate session, Sarah Slabaugh, DO, offers practical insights on identifying dysfunctional family patterns that may impact the presentation of ADHD symptoms in child and adolescent patients.
Filmed ahead of her 2025 Psych...
06/19/2025
Psych Congress Network
Timothy Wilens, MD
Videos
Managing Life Transitions in ADHD: Why Early Preparation is Critical
09/18/2024
Timothy Wilens, MD
Timothy Wilens, MD, provides practical clinical guidance for supporting patients with ADHD through life transitions.
Timothy Wilens, MD, provides practical clinical guidance for supporting patients with ADHD through life transitions.
Timothy Wilens, MD, provides...
09/18/2024
Psych Congress Network
Julie Carbray, PhD, APRN
Videos
Screening Tools for Adult and Pediatric ADHD
08/22/2024
Julie A. Carbray, PhD, APRN
Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, provides a quick overview of some of the most widely accessible screening tools for pediatric and adult attention-deficit/hyperactivity disorder.  
Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, provides a quick overview of some of the most widely accessible screening tools for pediatric and adult attention-deficit/hyperactivity disorder.  
Julie Carbray, PhD, FPMHNP-BC,...
08/22/2024
Psych Congress Network
Drs Mattingly, Price, Amann Part 3
Videos
Navigating ADHD Care Forward: The Future of ADHD
01/15/2024
In this roundtable discussion featuring a panel of experts, Dr Gregory Mattingly, Dr Richard Price, and Dr Birgit Amann focus on the evolving future of the ADHD landscape and address current unmet needs in ADHD treatment for both adult and...
In this roundtable discussion featuring a panel of experts, Dr Gregory Mattingly, Dr Richard Price, and Dr Birgit Amann focus on the evolving future of the ADHD landscape and address current unmet needs in ADHD treatment for both adult and...
In this roundtable discussion...
01/15/2024
Psych Congress Network
Drs Mattingly, Price, Amann Part 1
Videos
ADHD Unmasked: Current ADHD Treatment Landscape
01/15/2024
In this roundtable discussion featuring a panel of experts, Dr Gregory Mattingly, Dr Richard Price, and Dr Birgit Amann delve into the evolving landscape of ADHD treatment. The panelists discuss current treatment options, including...
In this roundtable discussion featuring a panel of experts, Dr Gregory Mattingly, Dr Richard Price, and Dr Birgit Amann delve into the evolving landscape of ADHD treatment. The panelists discuss current treatment options, including...
In this roundtable discussion...
01/15/2024
Psych Congress Network
Drs Mattingly, Price, Amann Part 2
Videos
Real-World Data Deep Dive: Viloxazine ER Compared With Atomoxetine for ADHD Study
12/12/2023
In this roundtable discussion featuring a panel of experts, Dr Gregory Mattingly, Dr Richard Price, and Dr Birgit Amann explore key findings from the real-world study comparing viloxazine ER with atomoxetine for ADHD treatment in adult and...
In this roundtable discussion featuring a panel of experts, Dr Gregory Mattingly, Dr Richard Price, and Dr Birgit Amann explore key findings from the real-world study comparing viloxazine ER with atomoxetine for ADHD treatment in adult and...
In this roundtable discussion...
12/12/2023
Psych Congress Network
Greg Mattingly, MD, and Elizabeth Judd, NP, MHS
Videos
How to Incorporate Non-Stimulants Into ADHD Treatment Plans
06/05/2023
Greg Mattingly, MD, and Elizabeth Judd, NP, MHS, discuss how clinicians can incorporate non-stimulant medication into their ADHD treatment plans.
Greg Mattingly, MD, and Elizabeth Judd, NP, MHS, discuss how clinicians can incorporate non-stimulant medication into their ADHD treatment plans.
Greg Mattingly, MD, and...
06/05/2023
Psych Congress Network
Manpreet Singh
Videos
Pediatric ADHD: Proper Diagnosis, Stimulant Therapy
12/16/2021
Manpreet Singh, MD, MS, discusses introducing stimulant therapy for ADHD management, differentiating pediatric ADHD from mood disorders, and gender or ethnic bias during diagnosis.
Manpreet Singh, MD, MS, discusses introducing stimulant therapy for ADHD management, differentiating pediatric ADHD from mood disorders, and gender or ethnic bias during diagnosis.
Manpreet Singh, MD, MS,...
12/16/2021
Psych Congress Network
Brooke Kempf, PMHNP-BC
Videos
Navigating Anxiety, Pain, and Mixed Features in Depressive Disorders
04/16/2026
Brooke Kempf, MSN, PMHNP-BC
Psych Congress Steering Committee member Brooke Kempf, PMHNP-BC, offers clinicians a practical framework for differentiating overlapping symptoms, anxious distress, and mixed features in MDD.
Psych Congress Steering Committee member Brooke Kempf, PMHNP-BC, offers clinicians a practical framework for differentiating overlapping symptoms, anxious distress, and mixed features in MDD.
Psych Congress Steering...
04/16/2026
Psych Congress Network
Philip Gehrman, PhD, CBSM, FAASM
Videos
Targeting Sleep to Improve Mental Health Outcomes
04/08/2026
Philip Gehrman, PhD
Psych Congress Steering Committee Partner Philip Gehrman, PhD, CBSM, FAASM, discusses how targeting sleep may improve outcomes for patients with co-occurring sleep and psychiatric disorders.
Psych Congress Steering Committee Partner Philip Gehrman, PhD, CBSM, FAASM, discusses how targeting sleep may improve outcomes for patients with co-occurring sleep and psychiatric disorders.
Psych Congress Steering...
04/08/2026
Psych Congress Network
Timothy Wilens, MD
Videos
Clinical Patterns of ADHD Comorbidities Across the Lifespan
04/01/2026
Timothy Wilens, MD
Timothy Wilens, MD, explores common patterns of attention-deficit/hyperactivity disorder (ADHD) psychiatric comorbidities throughout different developmental stages.
Timothy Wilens, MD, explores common patterns of attention-deficit/hyperactivity disorder (ADHD) psychiatric comorbidities throughout different developmental stages.
Timothy Wilens, MD, explores...
04/01/2026
Psych Congress Network
Brittany Albright MD, MPH
Videos
Taking a Patient-Centered Approach to Deprescribing in Psychiatry
03/13/2026
Brittany Albright, MD, MPH
In this insightful discussion, Brittany Albright, MD, MPH, Co-Chair, Psych Congress Elevate, offers a comprehensive overview of the role that deprescribing plays in effective psychiatric care.
In this insightful discussion, Brittany Albright, MD, MPH, Co-Chair, Psych Congress Elevate, offers a comprehensive overview of the role that deprescribing plays in effective psychiatric care.
In this insightful discussion,...
03/13/2026
Psych Congress Network
Chelsie Monroe, APN, PMHNP-BC
Videos
Is It Fatigue or Sleepiness? Identifying Narcolepsy in Practice
03/09/2026
Chelsie Monroe, PMHNP-BC, APN
Chelsie Monroe, APN, PMHNP-BC, discusses practical screening strategies, including the use of the Epworth Sleepiness Scale, the importance of collaboration with sleep specialists, and the clinical relevance of the orexin system.
Chelsie Monroe, APN, PMHNP-BC, discusses practical screening strategies, including the use of the Epworth Sleepiness Scale, the importance of collaboration with sleep specialists, and the clinical relevance of the orexin system.
Chelsie Monroe, APN, PMHNP-BC,...
03/09/2026
Psych Congress Network
Desiree Matthews, PMHNP-BC
Videos
Practical Guidance for Ethical AI Use in Psychiatry
03/06/2026
Desiree Matthews, PHMNP-BC
In this video, Desiree Matthews, PMHNP-BC, Steering Committee, Psych Congress, offers several practical considerations for mental health care providers contemplating the use of AI in psychiatric practice.
In this video, Desiree Matthews, PMHNP-BC, Steering Committee, Psych Congress, offers several practical considerations for mental health care providers contemplating the use of AI in psychiatric practice.
In this video, Desiree Matthews,...
03/06/2026
Psych Congress Network
Saundra Jain, MA, PsyD, LPC
Videos
Integrating Digital Therapeutics Into GAD Care
02/20/2026
Saundra Jain, MA, PsyD, LPC
Saundra Jain, MA, PsyD, LPC, discusses how clinicians can leverage digital therapeutics for the treatment of generalized anxiety disorder (GAD).
Saundra Jain, MA, PsyD, LPC, discusses how clinicians can leverage digital therapeutics for the treatment of generalized anxiety disorder (GAD).
Saundra Jain, MA, PsyD, LPC,...
02/20/2026
Psych Congress Network
Edward Kaftarian, MD
Videos
Maintaining HIPAA Compliance and Protecting Patient Data via Telehealth
02/09/2026
Edward Kaftarian, MD
Edward Kaftarian, MD, Steering Committee, Psych Congress, provides an update on the current state of HIPAA requirements for clinicians practicing via telehealth.
Edward Kaftarian, MD, Steering Committee, Psych Congress, provides an update on the current state of HIPAA requirements for clinicians practicing via telehealth.
Edward Kaftarian, MD, Steering...
02/09/2026
Psych Congress Network
Greg Mattingly, MD
Videos
VMAT-2 Inhibitor Differences and Dosing in Tardive Dyskinesia
01/09/2026
Greg Mattingly, MD
Psych Congress Co-Chair Greg Mattingly, MD, breaks down the key pharmacologic differences between the US Food and Drug Administration (FDA)-approved vesicular monoamine transporter 2 (VMAT-2) inhibitors for the treatment of TD.
Psych Congress Co-Chair Greg Mattingly, MD, breaks down the key pharmacologic differences between the US Food and Drug Administration (FDA)-approved vesicular monoamine transporter 2 (VMAT-2) inhibitors for the treatment of TD.
Psych Congress Co-Chair Greg...
01/09/2026
Psych Congress Network
Greg Mattingly, MD
Videos
VMAT-2 Inhibitor Differences and Dosing in Tardive Dyskinesia
01/09/2026
Greg Mattingly, MD
Psych Congress Co-Chair Greg Mattingly, MD, breaks down the key pharmacologic differences between the US Food and Drug Administration (FDA)-approved vesicular monoamine transporter 2 (VMAT-2) inhibitors for the treatment of TD.
Psych Congress Co-Chair Greg Mattingly, MD, breaks down the key pharmacologic differences between the US Food and Drug Administration (FDA)-approved vesicular monoamine transporter 2 (VMAT-2) inhibitors for the treatment of TD.
Psych Congress Co-Chair Greg...
01/09/2026
Psych Congress Network

News Articles

A boy's hand holding a pill that says ADHD
News
Open-Label Extension Trial Supports Long-Term Use of Viloxazine ER in Children and Adolescents
04/13/2026
A phase 3 open-label extension trial found viloxazine ER to be safe and effective for the long-term treatment of pediatric ADHD.
A phase 3 open-label extension trial found viloxazine ER to be safe and effective for the long-term treatment of pediatric ADHD.
A phase 3 open-label extension...
04/13/2026
Psych Congress Network
A teddy bear against a blue background wearing a mask and stethoscope.
News

ADHD Incidence Trends Accelerated After DSM-5 Changes and COVID-19 Disruptions
04/10/2026
Brionna Mendoza
Attention-deficit/hyperactivity disorder (ADHD) diagnosis rates in people younger than 30 years in British Columbia, Canada, rose steadily from 2003 to 2023 and appeared to accelerate after both DSM-5 implementation and the COVID-19 pandemic.
Attention-deficit/hyperactivity disorder (ADHD) diagnosis rates in people younger than 30 years in British Columbia, Canada, rose steadily from 2003 to 2023 and appeared to accelerate after both DSM-5 implementation and the COVID-19 pandemic.
Attention-deficit/hyperactivity...
04/10/2026
Psych Congress Network
News
Co-occurring ADHD Associated With Poorer Health Outcomes in Adults With Autism on Medicaid
02/02/2026
Grace Taylor, MS, MA
A large US Medicaid study finds that co-occurring attention-deficit/hyperactivity disorder (ADHD) is common among adults with autism and is linked to higher rates of substance use, cardiovascular conditions, and injury, while ADHD medication...
A large US Medicaid study finds that co-occurring attention-deficit/hyperactivity disorder (ADHD) is common among adults with autism and is linked to higher rates of substance use, cardiovascular conditions, and injury, while ADHD medication...
A large US Medicaid study finds...
02/02/2026
First Report Managed Care
A young boy sits at a desk in a classroom
News
Higher Screen Time Tied to ADHD Symptoms, Altered Brain Structure in Children
12/03/2025
Brionna Mendoza
Higher digital screen time in preadolescent children is associated with worsening attention-deficit/hyperactivity disorder (ADHD) symptoms and measurable alterations in brain structure.
Higher digital screen time in preadolescent children is associated with worsening attention-deficit/hyperactivity disorder (ADHD) symptoms and measurable alterations in brain structure.
Higher digital screen time in...
12/03/2025
Psych Congress Network
stethoscope, pills, and a brain
News
Stimulant Treatment for ADHD Associated With Psychosis and BD
09/25/2025
Maria Mantas
Stimulant use for the treatment of attention-deficit/hyperactivity disorder (ADHD) was associated with higher occurrence of psychotic symptoms, psychotic disorders, and bipolar disorder (BD), according to a systematic review.
Stimulant use for the treatment of attention-deficit/hyperactivity disorder (ADHD) was associated with higher occurrence of psychotic symptoms, psychotic disorders, and bipolar disorder (BD), according to a systematic review.
Stimulant use for the treatment...
09/25/2025
Psych Congress Network
An orange prescription container with generic pills spilling out in front of it
News
Early ADHD Drug Treatment Linked With Reduced Risk of Suicide, Substance Misuse, and Other Adverse Outcomes
08/27/2025
Jolynn Tumolo
Patients with attention-deficit/hyperactivity disorder (ADHD) who began drug treatment within 3 months of diagnosis had significantly reduced rates of suicidal behaviors, substance misuse, traffic accidents, and criminality.
Patients with attention-deficit/hyperactivity disorder (ADHD) who began drug treatment within 3 months of diagnosis had significantly reduced rates of suicidal behaviors, substance misuse, traffic accidents, and criminality.
Patients with...
08/27/2025
Psych Congress Network
plastic red heart with a stethoscope wrapped around it
News
Assessing the Cardiovascular Effects of ADHD Medications
06/09/2025
A recent systematic review and network meta-analysis assessed the cardiovascular effects of ADHD medications across children, adolescents, and adults with ADHD.
A recent systematic review and network meta-analysis assessed the cardiovascular effects of ADHD medications across children, adolescents, and adults with ADHD.
A recent systematic review and...
06/09/2025
Psych Congress Network
a boy with adhd
News
Youth With Symptomatic ADHD More Likely to Use Nicotine and Tobacco Later On
02/27/2025
Jolynn Tumolo
US youths with higher levels of ADHD symptom severity had significantly higher odds of initiating e-cigarette, cigarette, and other tobacco use over a 9-year follow-up.
US youths with higher levels of ADHD symptom severity had significantly higher odds of initiating e-cigarette, cigarette, and other tobacco use over a 9-year follow-up.
US youths with higher levels of...
02/27/2025
Psych Congress Network
Study Offers Practical Recommendations to Improve Diagnosis and Care for Women With ADHD
News
Study Offers Practical Recommendations to Improve Diagnosis and Care for Women With ADHD
02/26/2025
Evi Arthur
A new mixed-methods study published in the Journal of Attention Disorders confirms this research and investigates the barriers to care women diagnosed with ADHD face, as well as what practical changes clinicians can make to create more...
A new mixed-methods study published in the Journal of Attention Disorders confirms this research and investigates the barriers to care women diagnosed with ADHD face, as well as what practical changes clinicians can make to create more...
A new mixed-methods study...
02/26/2025
Psych Congress Network
A child sleeps in bed on her stomach with her mouth hanging open
News
Loudness of Snoring May Indicate Greater Hyperactivity in Children and Adolescents
01/16/2025
Brionna Mendoza
Loudness of snoring, regardless of hypoxic burden and obstructive sleep apnea syndrome severity (OSAS), may contribute to hyperactivity in pediatric patients, according to an observational prospective study published in Sleep Medicine.
Loudness of snoring, regardless of hypoxic burden and obstructive sleep apnea syndrome severity (OSAS), may contribute to hyperactivity in pediatric patients, according to an observational prospective study published in Sleep Medicine.
Loudness of snoring, regardless...
01/16/2025
Psych Congress Network
Three illustrated faces, one sad, one neutral, one happy, with a human hand picking up the happy face
News
Semaglutide May Improve Motivation in MDD, Small Trial Finds
05/04/2026
Brionna Mendoza
A randomized clinical trial published in JAMA Psychiatry found that oral semaglutide may improve effort-based decision-making in adults with major depressive disorder (MDD).
A randomized clinical trial published in JAMA Psychiatry found that oral semaglutide may improve effort-based decision-making in adults with major depressive disorder (MDD).
A randomized clinical trial...
05/04/2026
Psych Congress Network
A patient receives psychedelic-assisted therapy
News
Presidential Executive Order Seeks to Expand Psychedelic Access for Tough-To-Treat Mental Illnesses
04/29/2026
Brionna Mendoza
President Donald J. Trump signed an executive order titled “Accelerating Medical Treatments for Serious Mental Illness,” which aims to expand psychedelic therapy access for significant mental health issues, such as suicidality, major...
President Donald J. Trump signed an executive order titled “Accelerating Medical Treatments for Serious Mental Illness,” which aims to expand psychedelic therapy access for significant mental health issues, such as suicidality, major...
President Donald J. Trump signed...
04/29/2026
Psych Congress Network
a female soldier stands in front of a row of American flags
News
TMS Improves Residential Therapy Outcomes in Combat-Related PTSD
04/22/2026
Maria Mantas
Active navigated transcranial magnetic stimulation (TMS) added to intensive residential treatment was associated with greater reduction of symptoms in patients with combat-related posttraumatic stress disorder (PTSD) than sham TMS.
Active navigated transcranial magnetic stimulation (TMS) added to intensive residential treatment was associated with greater reduction of symptoms in patients with combat-related posttraumatic stress disorder (PTSD) than sham TMS.
Active navigated transcranial...
04/22/2026
Psych Congress Network
A doctor sits at a table holding a pill bottle in one hand while filling out paperwork
News
Algorithm-Guided Treatment Improves Outcomes in Major Depressive Disorder
04/14/2026
Brionna Mendoza
A systematic review published in Frontiers in Psychiatry reports that algorithm-guided treatment (AGT) is generally associated with improved remission rates and more timely treatment modifications compared with treatment as usual (TAU).
A systematic review published in Frontiers in Psychiatry reports that algorithm-guided treatment (AGT) is generally associated with improved remission rates and more timely treatment modifications compared with treatment as usual (TAU).
A systematic review published in...
04/14/2026
Psych Congress Network
a person attempts to pick up a glass of water
News
Valbenazine Demonstrates Higher Persistence vs Deutetrabenazine in TD Patients
04/14/2026
Maria Mantas
Neurocrine Biosciences reported new real-world evidence demonstrating higher treatment persistence with valbenazine (Ingrezza) compared with deutetrabenazine (Austedo XR) among adults with tardive dyskinesia (TD).
Neurocrine Biosciences reported new real-world evidence demonstrating higher treatment persistence with valbenazine (Ingrezza) compared with deutetrabenazine (Austedo XR) among adults with tardive dyskinesia (TD).
Neurocrine Biosciences reported...
04/14/2026
Psych Congress Network
A boy's hand holding a pill that says ADHD
News
Open-Label Extension Trial Supports Long-Term Use of Viloxazine ER in Children and Adolescents
04/13/2026
A phase 3 open-label extension trial found viloxazine ER to be safe and effective for the long-term treatment of pediatric ADHD.
A phase 3 open-label extension trial found viloxazine ER to be safe and effective for the long-term treatment of pediatric ADHD.
A phase 3 open-label extension...
04/13/2026
Psych Congress Network
A teddy bear against a blue background wearing a mask and stethoscope.
News

ADHD Incidence Trends Accelerated After DSM-5 Changes and COVID-19 Disruptions
04/10/2026
Brionna Mendoza
Attention-deficit/hyperactivity disorder (ADHD) diagnosis rates in people younger than 30 years in British Columbia, Canada, rose steadily from 2003 to 2023 and appeared to accelerate after both DSM-5 implementation and the COVID-19 pandemic.
Attention-deficit/hyperactivity disorder (ADHD) diagnosis rates in people younger than 30 years in British Columbia, Canada, rose steadily from 2003 to 2023 and appeared to accelerate after both DSM-5 implementation and the COVID-19 pandemic.
Attention-deficit/hyperactivity...
04/10/2026
Psych Congress Network
A profile of a person split in half, one half teal and the other purple, with a swirl line over the head
News
Higher Risk of Premature Death Found in Bipolar II Disorder
04/07/2026
Brionna Mendoza
Bipolar II disorder (BD-II) is associated with significantly increased mortality, according to a large population-based cohort study published in JAMA Network Open.
Bipolar II disorder (BD-II) is associated with significantly increased mortality, according to a large population-based cohort study published in JAMA Network Open.
Bipolar II disorder (BD-II) is...
04/07/2026
Psych Congress Network
a man with depression looks out a window major depressive disorder
Research Summary
Psilocybin Produces Mixed Outcomes in Phase 2b MDD Study
04/01/2026
Brionna Mendoza
A Phase 2b randomized clinical trial found nonsignificant differences in response rate between psilocybin 25 mg, psilocybin 5 mg, and placebo with supporting psychotherapy in treatment-resistant major depressive disorder (MDD).
A Phase 2b randomized clinical trial found nonsignificant differences in response rate between psilocybin 25 mg, psilocybin 5 mg, and placebo with supporting psychotherapy in treatment-resistant major depressive disorder (MDD).
A Phase 2b randomized clinical...
04/01/2026
Psych Congress Network
spilled bottle of white pills
News
Tazbentetol Demonstrates Early Symptom Improvement in Phase 2 Schizophrenia Trial
04/01/2026
Maria Mantas
Interim results from a phase 2 randomized, double-blind, placebo-controlled trial of tazbentetol demonstrated early signals of efficacy across schizophrenia symptom domains.
Interim results from a phase 2 randomized, double-blind, placebo-controlled trial of tazbentetol demonstrated early signals of efficacy across schizophrenia symptom domains.
Interim results from a phase 2...
04/01/2026
Psych Congress Network

Podcasts

Dr Rakesh Jain
Podcasts
Targeting Hyperactivity and Impulsivity in Adolescents: A Look at Viloxazine ER
04/17/2025
Rakesh Jain, MD, MPH, RD
Join Rakesh Jain, MD, MPH, as he explores the role of viloxazine extended-release (ER) in targeting hyperactivity and impulsivity in adolescents with ADHD.
Join Rakesh Jain, MD, MPH, as he explores the role of viloxazine extended-release (ER) in targeting hyperactivity and impulsivity in adolescents with ADHD.
Join Rakesh Jain, MD, MPH, as he...
04/17/2025
Psych Congress Network
Dr Greg Mattingly
Podcasts
Viloxazine ER: A New Era in ADHD Treatment?
04/17/2025
Greg Mattingly, MD
Join Greg Mattingly, MD, as he discusses the evolving ADHD treatment landscape, in particular extended-release viloxazine
Join Greg Mattingly, MD, as he discusses the evolving ADHD treatment landscape, in particular extended-release viloxazine
Join Greg Mattingly, MD, as he...
04/17/2025
Psych Congress Network
Greg Mattingly, MD
Podcasts
Managing Pediatric ADHD and Stress During the Holidays
12/03/2021
Greg Mattingly, MD
Greg Mattingly, MD, shares tips and advice on managing pediatric ADHD and stress through the holiday season.
Greg Mattingly, MD, shares tips and advice on managing pediatric ADHD and stress through the holiday season.
Greg Mattingly, MD, shares tips...
12/03/2021
Psych Congress Network
Rakesh Jain and Craig Chepke
Podcasts
Psych Congress Family & Friends Podcast, Episode 8: Beyond the Headlines: The Good, The Bad, and The Ugly of SSRIs
10/09/2025
Rakesh Jain, MD, MPH, RD; Craig Chepke, MD, DFAPA; Ragy R. Girgis, MD, MS
In this episode, Drs Rakesh Jain and Craig Chepke are joined by Dr Ragy Girgis of Columbia University to explore the small but important nuances around antidepressants, black box warnings, and violence risk in untreated psychosis.
In this episode, Drs Rakesh Jain and Craig Chepke are joined by Dr Ragy Girgis of Columbia University to explore the small but important nuances around antidepressants, black box warnings, and violence risk in untreated psychosis.
In this episode, Drs Rakesh Jain...
10/09/2025
Psych Congress Network
Craig Chepke and Rakesh Jain
Podcasts
Psych Congress Family & Friends Podcast, Episode 7: Sleep is the Foundation of Mental Health
09/12/2025
Craig Chepke, MD, DFAPA; Rakesh Jain, MD, MPH, RD
Sleep–wake disorders are clinically significant and too often overlooked in psychiatric practice. Drs. Rakesh Jain and Craig Chepke share practical strategies for recognizing and treating insomnia, hypersomnia, and obstructive sleep apnea.
Sleep–wake disorders are clinically significant and too often overlooked in psychiatric practice. Drs. Rakesh Jain and Craig Chepke share practical strategies for recognizing and treating insomnia, hypersomnia, and obstructive sleep apnea.
Sleep–wake disorders are...
09/12/2025
Psych Congress Network
Rakesh Jain and Craig Chepke
Podcasts
Psych Congress Family & Friends Podcast, Episode 6: Psychiatry Is the Specialty That Speaks for Those Without a Voice
09/08/2025
Rakesh Jain, MD, MPH, RD; Craig Chepke, MD, DFAPA
In this episode, Drs Rakesh Jain and Craig Chepke explore why fibromyalgia belongs in psychiatry’s wheelhouse and address the stigma patients face every day.
In this episode, Drs Rakesh Jain and Craig Chepke explore why fibromyalgia belongs in psychiatry’s wheelhouse and address the stigma patients face every day.
In this episode, Drs Rakesh Jain...
09/08/2025
Psych Congress Network
Craig Chepke and Rakesh Jain
Podcasts
Psych Congress Family & Friends Podcast, Episode 5: We’re Too Addicted to Our Own Good Ideas
08/25/2025
Craig Chepke, MD, DFAPA; Rakesh Jain, MD, MPH, RD
In this episode, Drs Rakesh Jain and Craig Chepke reflect on how the words we use—and the habits we form—shape the way we practice. The pair also take a fresh look at the serotonin story, talk through new ways of understanding depression, and...
In this episode, Drs Rakesh Jain and Craig Chepke reflect on how the words we use—and the habits we form—shape the way we practice. The pair also take a fresh look at the serotonin story, talk through new ways of understanding depression, and...
In this episode, Drs Rakesh Jain...
08/25/2025
Psych Congress Network
craig chepke and rakesh jain
Podcasts
Psych Congress Family & Friends Podcast, Episode 4: Every Pill is a Choice
07/25/2025
Craig Chepke, MD, DFAPA; Rakesh Jain, MD, MPH, RD
Through a positive psychiatry lens, Drs Rakesh Jain and Craig Chepke reflect on recent research, the challenges of psychiatric diagnosis, and why every treatment decision should begin with a deep understanding of the person in front of us.
Through a positive psychiatry lens, Drs Rakesh Jain and Craig Chepke reflect on recent research, the challenges of psychiatric diagnosis, and why every treatment decision should begin with a deep understanding of the person in front of us.
Through a positive psychiatry...
07/25/2025
Psych Congress Network
Dr Rakesh Jain
Podcasts
Targeting Hyperactivity and Impulsivity in Adolescents: A Look at Viloxazine ER
04/17/2025
Rakesh Jain, MD, MPH, RD
Join Rakesh Jain, MD, MPH, as he explores the role of viloxazine extended-release (ER) in targeting hyperactivity and impulsivity in adolescents with ADHD.
Join Rakesh Jain, MD, MPH, as he explores the role of viloxazine extended-release (ER) in targeting hyperactivity and impulsivity in adolescents with ADHD.
Join Rakesh Jain, MD, MPH, as he...
04/17/2025
Psych Congress Network
Dr Greg Mattingly
Podcasts
Viloxazine ER: A New Era in ADHD Treatment?
04/17/2025
Greg Mattingly, MD
Join Greg Mattingly, MD, as he discusses the evolving ADHD treatment landscape, in particular extended-release viloxazine
Join Greg Mattingly, MD, as he discusses the evolving ADHD treatment landscape, in particular extended-release viloxazine
Join Greg Mattingly, MD, as he...
04/17/2025
Psych Congress Network
Rakesh and Craig
Podcasts
Weighing the Options: Medication, Lifestyle, and the Path to Wellness
03/26/2025
Rakesh Jain, MD, MPH, RD; Craig Chepke, MD, DFAPA
In this episode, Dr Rakesh Jain and Dr Craig Chepke explore medication-induced weight gain in schizophrenia treatment and how clinicians can help patients take control of their health, mind, and body.
In this episode, Dr Rakesh Jain and Dr Craig Chepke explore medication-induced weight gain in schizophrenia treatment and how clinicians can help patients take control of their health, mind, and body.
In this episode, Dr Rakesh Jain...
03/26/2025
Psych Congress Network
psych congress family and friends podcast
Podcasts
Gut Feelings: Tackling Medication-Induced Nausea
02/05/2025
Join Dr Craig Chepke and Dr Rakesh Jain in this episode of the Psych Congress Family & Friends Podcast as they tackle a topic that affects so many patients receiving psychiatric treatment: nausea!
Join Dr Craig Chepke and Dr Rakesh Jain in this episode of the Psych Congress Family & Friends Podcast as they tackle a topic that affects so many patients receiving psychiatric treatment: nausea!
Join Dr Craig Chepke and Dr...
02/05/2025
Psych Congress Network
psych congress family and friends podcast
Podcasts
A New Beginning, and a Fond Farewell
01/06/2025
Craig Chepke, MD, DFAPA; Rakesh Jain, MD, MPH, RD
Join Dr Rakesh Jain and Dr Craig Chepke for a discussion of feelings surrounding the recent passing of Dr Vladimir Maletic leads to an exploration of a topic near and dear to Dr Maletic's heart—the role of norepinephrine in clinical practice.
Join Dr Rakesh Jain and Dr Craig Chepke for a discussion of feelings surrounding the recent passing of Dr Vladimir Maletic leads to an exploration of a topic near and dear to Dr Maletic's heart—the role of norepinephrine in clinical practice.
Join Dr Rakesh Jain and Dr Craig...
01/06/2025
Psych Congress Network

Commentary

a girl playing a game on a tablet while lying on her stomach
Commentary
Digital Therapeutics: A Different Treatment Modality for ADHD
04/23/2026
This article reviews the role of digital therapeutics (DTx) as an adjunctive treatment modality for ADHD, highlighting FDA‑cleared products alongside investigational interventions. It summarizes clinical evidence, safety, and use...
This article reviews the role of digital therapeutics (DTx) as an adjunctive treatment modality for ADHD, highlighting FDA‑cleared products alongside investigational interventions. It summarizes clinical evidence, safety, and use...
This article reviews the role of...
04/23/2026
Psych Congress Network
Stressed mother next to crib with baby
Commentary
Postpartum Distress in Women With ADHD: Risks, Recognition, and Evidence-Based Management
09/25/2025
This article explores the challenges of postpartum distress in women with ADHD, highlighting how symptoms and psychiatric comorbidities can intensify during pregnancy and the postpartum period. It reviews current evidence, treatment...
This article explores the challenges of postpartum distress in women with ADHD, highlighting how symptoms and psychiatric comorbidities can intensify during pregnancy and the postpartum period. It reviews current evidence, treatment...
This article explores the...
09/25/2025
Psych Congress Network
Rx pad in the shape of a cell phone with pills on the screen
Commentary
Telehealth Stimulant Prescribing and Substance Misuse Risk: What the Evidence Really Says
09/23/2025
This article reviews two large studies that evaluated whether telehealth prescribing of stimulants for ADHD increases substance misuse risk.
This article reviews two large studies that evaluated whether telehealth prescribing of stimulants for ADHD increases substance misuse risk.
This article reviews two large...
09/23/2025
Psych Congress Network
Hyper child jumps on couch while mom holds head in hands
Commentary
Beyond Symptoms: The Impact of Stigma in Families of Children With ADHD
09/19/2025
This article reviews how stigma affects families of children with ADHD—undermining help‑seeking, adherence, and well‑being—and offers clinician strategies to counter it, including destigmatizing language, brief caregiver screening, family...
This article reviews how stigma affects families of children with ADHD—undermining help‑seeking, adherence, and well‑being—and offers clinician strategies to counter it, including destigmatizing language, brief caregiver screening, family...
This article reviews how stigma...
09/19/2025
Psych Congress Network
a teenager's hand putting a bag of white pills into another teenager's hand.
Commentary
Understanding Abuse Potential Across ADHD Therapies: What Clinicians Need to Know
06/13/2025
As stimulant prescriptions for ADHD continue to rise, so does concern about their nonmedical use—particularly among adolescents and young adults.
As stimulant prescriptions for ADHD continue to rise, so does concern about their nonmedical use—particularly among adolescents and young adults.
As stimulant prescriptions for...
06/13/2025
Psych Congress Network
empty pill box on calendar with days crossed off
Commentary
Adherence and Acceptability: How Viloxazine ER Stacks Up Against Other ADHD Medications
06/13/2025
This article examines how viloxazine ER may improve adherence to ADHD treatment compared to other medications. As a non-stimulant with once-daily dosing, rapid onset, and low risk of misuse or cardiovascular issues, viloxazine ER addresses...
This article examines how viloxazine ER may improve adherence to ADHD treatment compared to other medications. As a non-stimulant with once-daily dosing, rapid onset, and low risk of misuse or cardiovascular issues, viloxazine ER addresses...
This article examines how...
06/13/2025
Psych Congress Network
A smily face button, post-it notes with A-D-H-D, and two puzzle pieces
Commentary
Combination Therapy in ADHD: When and How to Augment Treatment Safely
06/11/2025
As ADHD management becomes more nuanced, combination therapy is gaining attention as a pragmatic solution for patients who experience suboptimal outcomes or intolerable side effects on monotherapy.
As ADHD management becomes more nuanced, combination therapy is gaining attention as a pragmatic solution for patients who experience suboptimal outcomes or intolerable side effects on monotherapy.
As ADHD management becomes more...
06/11/2025
Psych Congress Network
Hand blocking small red sad face icons from large green smiling icon
Commentary
Viloxazine ER’s Impact on Comorbid Conditions: A Broader Approach to ADHD Management
06/05/2025
Managing attention-deficit/hyperactivity disorder (ADHD) often means navigating a maze of overlapping conditions—mood instability, anxiety, executive dysfunction, and more. This article explores how viloxazine ER, a non-stimulant with dual...
Managing attention-deficit/hyperactivity disorder (ADHD) often means navigating a maze of overlapping conditions—mood instability, anxiety, executive dysfunction, and more. This article explores how viloxazine ER, a non-stimulant with dual...
Managing...
06/05/2025
Psych Congress Network
Pharmacokinetics icon
Commentary
Pharmacokinetics of Viloxazine ER: What to Expect From Onset to Duration
06/05/2025
This article provides a practical breakdown of viloxazine ER’s absorption, metabolism, and elimination profiles, explaining how these features support its once-daily dosing and 24-hour symptom coverage.
This article provides a practical breakdown of viloxazine ER’s absorption, metabolism, and elimination profiles, explaining how these features support its once-daily dosing and 24-hour symptom coverage.
This article provides a...
06/05/2025
Psych Congress Network
A woman sleeping peacefully
Commentary
ADHD and Sleep: Why Non-Stimulants Might Be the Right Choice (Part 3)
06/02/2025
Sleep disturbances remain one of the most challenging aspects of ADHD management across all age groups, and stimulants, while effective for core symptoms, often exacerbate these issues.
Sleep disturbances remain one of the most challenging aspects of ADHD management across all age groups, and stimulants, while effective for core symptoms, often exacerbate these issues.
Sleep disturbances remain one of...
06/02/2025
Psych Congress Network
a girl playing a game on a tablet while lying on her stomach
Commentary
Digital Therapeutics: A Different Treatment Modality for ADHD
04/23/2026
This article reviews the role of digital therapeutics (DTx) as an adjunctive treatment modality for ADHD, highlighting FDA‑cleared products alongside investigational interventions. It summarizes clinical evidence, safety, and use...
This article reviews the role of digital therapeutics (DTx) as an adjunctive treatment modality for ADHD, highlighting FDA‑cleared products alongside investigational interventions. It summarizes clinical evidence, safety, and use...
This article reviews the role of...
04/23/2026
Psych Congress Network
Stressed mother next to crib with baby
Commentary
Postpartum Distress in Women With ADHD: Risks, Recognition, and Evidence-Based Management
09/25/2025
This article explores the challenges of postpartum distress in women with ADHD, highlighting how symptoms and psychiatric comorbidities can intensify during pregnancy and the postpartum period. It reviews current evidence, treatment...
This article explores the challenges of postpartum distress in women with ADHD, highlighting how symptoms and psychiatric comorbidities can intensify during pregnancy and the postpartum period. It reviews current evidence, treatment...
This article explores the...
09/25/2025
Psych Congress Network
Rx pad in the shape of a cell phone with pills on the screen
Commentary
Telehealth Stimulant Prescribing and Substance Misuse Risk: What the Evidence Really Says
09/23/2025
This article reviews two large studies that evaluated whether telehealth prescribing of stimulants for ADHD increases substance misuse risk.
This article reviews two large studies that evaluated whether telehealth prescribing of stimulants for ADHD increases substance misuse risk.
This article reviews two large...
09/23/2025
Psych Congress Network
Hyper child jumps on couch while mom holds head in hands
Commentary
Beyond Symptoms: The Impact of Stigma in Families of Children With ADHD
09/19/2025
This article reviews how stigma affects families of children with ADHD—undermining help‑seeking, adherence, and well‑being—and offers clinician strategies to counter it, including destigmatizing language, brief caregiver screening, family...
This article reviews how stigma affects families of children with ADHD—undermining help‑seeking, adherence, and well‑being—and offers clinician strategies to counter it, including destigmatizing language, brief caregiver screening, family...
This article reviews how stigma...
09/19/2025
Psych Congress Network
a teenager's hand putting a bag of white pills into another teenager's hand.
Commentary
Understanding Abuse Potential Across ADHD Therapies: What Clinicians Need to Know
06/13/2025
As stimulant prescriptions for ADHD continue to rise, so does concern about their nonmedical use—particularly among adolescents and young adults.
As stimulant prescriptions for ADHD continue to rise, so does concern about their nonmedical use—particularly among adolescents and young adults.
As stimulant prescriptions for...
06/13/2025
Psych Congress Network
empty pill box on calendar with days crossed off
Commentary
Adherence and Acceptability: How Viloxazine ER Stacks Up Against Other ADHD Medications
06/13/2025
This article examines how viloxazine ER may improve adherence to ADHD treatment compared to other medications. As a non-stimulant with once-daily dosing, rapid onset, and low risk of misuse or cardiovascular issues, viloxazine ER addresses...
This article examines how viloxazine ER may improve adherence to ADHD treatment compared to other medications. As a non-stimulant with once-daily dosing, rapid onset, and low risk of misuse or cardiovascular issues, viloxazine ER addresses...
This article examines how...
06/13/2025
Psych Congress Network
A smily face button, post-it notes with A-D-H-D, and two puzzle pieces
Commentary
Combination Therapy in ADHD: When and How to Augment Treatment Safely
06/11/2025
As ADHD management becomes more nuanced, combination therapy is gaining attention as a pragmatic solution for patients who experience suboptimal outcomes or intolerable side effects on monotherapy.
As ADHD management becomes more nuanced, combination therapy is gaining attention as a pragmatic solution for patients who experience suboptimal outcomes or intolerable side effects on monotherapy.
As ADHD management becomes more...
06/11/2025
Psych Congress Network
Hand blocking small red sad face icons from large green smiling icon
Commentary
Viloxazine ER’s Impact on Comorbid Conditions: A Broader Approach to ADHD Management
06/05/2025
Managing attention-deficit/hyperactivity disorder (ADHD) often means navigating a maze of overlapping conditions—mood instability, anxiety, executive dysfunction, and more. This article explores how viloxazine ER, a non-stimulant with dual...
Managing attention-deficit/hyperactivity disorder (ADHD) often means navigating a maze of overlapping conditions—mood instability, anxiety, executive dysfunction, and more. This article explores how viloxazine ER, a non-stimulant with dual...
Managing...
06/05/2025
Psych Congress Network
Pharmacokinetics icon
Commentary
Pharmacokinetics of Viloxazine ER: What to Expect From Onset to Duration
06/05/2025
This article provides a practical breakdown of viloxazine ER’s absorption, metabolism, and elimination profiles, explaining how these features support its once-daily dosing and 24-hour symptom coverage.
This article provides a practical breakdown of viloxazine ER’s absorption, metabolism, and elimination profiles, explaining how these features support its once-daily dosing and 24-hour symptom coverage.
This article provides a...
06/05/2025
Psych Congress Network
A woman sleeping peacefully
Commentary
ADHD and Sleep: Why Non-Stimulants Might Be the Right Choice (Part 3)
06/02/2025
Sleep disturbances remain one of the most challenging aspects of ADHD management across all age groups, and stimulants, while effective for core symptoms, often exacerbate these issues.
Sleep disturbances remain one of the most challenging aspects of ADHD management across all age groups, and stimulants, while effective for core symptoms, often exacerbate these issues.
Sleep disturbances remain one of...
06/02/2025
Psych Congress Network

Quizzes

a girl playing a game on a tablet while lying on her stomach
Quiz
Test Your Knowledge—Digital Therapeutics: A Different Treatment Modality for ADHD
04/23/2026
How familiar are you with DTx for the treatment of attention-deficit/hyperactivity disorder? Test your knowledge with this short, multiple-choice quiz.
How familiar are you with DTx for the treatment of attention-deficit/hyperactivity disorder? Test your knowledge with this short, multiple-choice quiz.
How familiar are you with DTx...
04/23/2026
Psych Congress Network
A boy's hand holding a pill that says ADHD
Quiz
Long-Term Effects of Viloxazine ER in Treatment of Pediatric ADHD
04/23/2026
Ready to apply the data? Test your knowledge of viloxazine ER for the long-term treatment of pediatric ADHD.
Ready to apply the data? Test your knowledge of viloxazine ER for the long-term treatment of pediatric ADHD.
Ready to apply the data? Test...
04/23/2026
Psych Congress Network
blocks spelling out the word "quiz"
Quiz
Screen Time, Brain Structure, and ADHD in Children
02/12/2026
Maria Mantas
Do you remember what the research says? Test your knowledge with this quick quiz!
Do you remember what the research says? Test your knowledge with this quick quiz!
Do you remember what the...
02/12/2026
Psych Congress Network
illustration of a laptop screen displaying a test
Quiz
Stimulants and Psychosis Risk in ADHD
12/22/2025
Maria Mantas
Do you remember the findings from this systematic review?
Do you remember the findings from this systematic review?
Do you remember the findings...
12/22/2025
Psych Congress Network
A woman sleeping peacefully
Quiz
Test Your Knowledge – ADHD and Sleep: Why Non-Stimulants Might Be the Right Choice (Part 3)
10/09/2025
Sleep and ADHD intersect—see if your management playbook is up to date in 3 quick questions.
Sleep and ADHD intersect—see if your management playbook is up to date in 3 quick questions.
Sleep and ADHD intersect—see if...
10/09/2025
Psych Congress Network
Blocks that spell ADHD with pills and a stethoscope
Quiz
Test Your Knowledge – The Rise of Non-Stimulant ADHD Treatments: A Paradigm Shift?
10/08/2025
Rethink ADHD beyond stimulants—test your non-stimulant savvy with 3 quick questions.
Rethink ADHD beyond stimulants—test your non-stimulant savvy with 3 quick questions.
Rethink ADHD beyond...
10/08/2025
Psych Congress Network
A boy sleeping peacefully.
Quiz
Test Your Knowledge – ADHD and Sleep: Why Non-Stimulants Might Be the Right Choice (Part 2)
09/29/2025
How well do you know the evidence on ADHD and sleep? Take this quick quiz to find out.
How well do you know the evidence on ADHD and sleep? Take this quick quiz to find out.
How well do you know the...
09/29/2025
Psych Congress Network
a cloud with three z's
Quiz
Test Your Knowledge – ADHD and Sleep: Why Non-Stimulants Might Be the Right Choice (Part 1)
09/19/2025
Can you optimize ADHD control and protect sleep? Take this quick quiz on viloxazine ER’s role in patients with nighttime challenges.
Can you optimize ADHD control and protect sleep? Take this quick quiz on viloxazine ER’s role in patients with nighttime challenges.
Can you optimize ADHD control...
09/19/2025
Psych Congress Network
Dr Greg Mattingly
Quiz
Test Your Knowledge – Viloxazine ER: A New Era in ADHD Treatment?
09/17/2025
How well do you know the clinical impact and unique mechanism of viloxazine ER? Take this short quiz to find out.
How well do you know the clinical impact and unique mechanism of viloxazine ER? Take this short quiz to find out.
How well do you know the...
09/17/2025
Psych Congress Network
medication
Quiz
Test Your Knowledge: Study Results Link Non-Stimulant ADHD Therapy and Prescription Stimulant Misuse in Adolescents
09/09/2025
What does research reveal about the risk of non-stimulants? Test your understanding of ADHD treatment and stimulant misuse.
What does research reveal about the risk of non-stimulants? Test your understanding of ADHD treatment and stimulant misuse.
What does research reveal about...
09/09/2025
Psych Congress Network
a printed test, pencil, and clock on a desk
Quiz
Mortality Risk in Bipolar II Disorder
04/30/2026
Maria Mantas
What was the association between all-cause mortality risk and bipolar II disorder? Test your knowledge with this quiz!
What was the association between all-cause mortality risk and bipolar II disorder? Test your knowledge with this quiz!
What was the association between...
04/30/2026
Psych Congress Network
an illustrated laptop screen displaying a quiz
Quiz
PGx Testing in MDD
04/27/2026
Maria Mantas
Can you recall how the use of pharmacogenomic testing impacted treatment outcomes in major depressive disorder (MDD)?
Can you recall how the use of pharmacogenomic testing impacted treatment outcomes in major depressive disorder (MDD)?
Can you recall how the use of...
04/27/2026
Psych Congress Network
a girl playing a game on a tablet while lying on her stomach
Quiz
Test Your Knowledge—Digital Therapeutics: A Different Treatment Modality for ADHD
04/23/2026
How familiar are you with DTx for the treatment of attention-deficit/hyperactivity disorder? Test your knowledge with this short, multiple-choice quiz.
How familiar are you with DTx for the treatment of attention-deficit/hyperactivity disorder? Test your knowledge with this short, multiple-choice quiz.
How familiar are you with DTx...
04/23/2026
Psych Congress Network
A boy's hand holding a pill that says ADHD
Quiz
Long-Term Effects of Viloxazine ER in Treatment of Pediatric ADHD
04/23/2026
Ready to apply the data? Test your knowledge of viloxazine ER for the long-term treatment of pediatric ADHD.
Ready to apply the data? Test your knowledge of viloxazine ER for the long-term treatment of pediatric ADHD.
Ready to apply the data? Test...
04/23/2026
Psych Congress Network
Brooke Kempf, PMHNP-BC, and Jonathan Meyer, MD
Quiz
Why should anticholinergics be avoided in TD?
04/17/2026
Maria Mantas
Do you remember why anticholinergic agents aren't appropriate treatment options for tardive dyskinesia? Test your knowledge with this quiz!
Do you remember why anticholinergic agents aren't appropriate treatment options for tardive dyskinesia? Test your knowledge with this quiz!
Do you remember why...
04/17/2026
Psych Congress Network
Brooke Kempf, PMHNP-BC, and Jonathan Meyer, MD
Quiz
Why should anticholinergics be avoided in TD?
04/17/2026
Maria Mantas
Do you remember why anticholinergic agents aren't appropriate treatment options for tardive dyskinesia? Test your knowledge with this quiz!
Do you remember why anticholinergic agents aren't appropriate treatment options for tardive dyskinesia? Test your knowledge with this quiz!
Do you remember why...
04/17/2026
Psych Congress Network
Edward Kaftarian, MD
Quiz
Legal Considerations in Cross-State Telepsychiatry
03/23/2026
Maria Mantas
Test your knowledge with this faculty insights quiz!
Test your knowledge with this faculty insights quiz!
Test your knowledge with this...
03/23/2026
Psych Congress Network
a printed test, pencil, and clock on a desk
Quiz
Pharmacologic Intervention in Bulimia Nervosa
02/26/2026
Maria Mantas
Do you remember what the APA guideline recommends? Test your knowledge with this quiz!
Do you remember what the APA guideline recommends? Test your knowledge with this quiz!
Do you remember what the APA...
02/26/2026
Psych Congress Network
blocks spelling out the word "quiz"
Quiz
Screen Time, Brain Structure, and ADHD in Children
02/12/2026
Maria Mantas
Do you remember what the research says? Test your knowledge with this quick quiz!
Do you remember what the research says? Test your knowledge with this quick quiz!
Do you remember what the...
02/12/2026
Psych Congress Network
An illustration of a pencil marking answers on a quiz sheet.
Quiz
Intranasal Esketamine Dosage for Adult MDD
02/04/2026
Brionna Mendoza
Test your prescribing and administration knowledge with this quiz!
Test your prescribing and administration knowledge with this quiz!
Test your prescribing and...
02/04/2026
Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Insights
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use